“…Several enzymes in this family are potential drug targets, including plasmepsin II, beta‐secretase/BACE1, cathepsin D, and renin, which are implicated in malaria, Alzheimer's disease, breast cancer, and hypertension, respectively 29 . More generally, mutations to the PS domain can direct folding into slightly altered conformations, even following PS removal, implying a “protein memory” effect 27,57 . Based on this phenomenon, pro‐sequence engineering 58 has been used to modulate the stability, specificity, and/or catalytic efficiency of proteins involved in industrial applications such as papain, keratinase, and nerve growth factor proteins 27,28,59 .…”